MS-H Vaccine

RSS

Mycoplasma synoviae (live)

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR) for MS-H Vaccine. It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use MS-H Vaccine.

For practical information about using MS-H Vaccine, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.

This EPAR was last updated on 21/05/2019

Authorisation details

Product details
Name
MS-H Vaccine
Agency product number
EMEA/V/C/000161
Active substance
Mycoplasma synoviae strain MS-H
International non-proprietary name (INN) or common name
Mycoplasma synoviae (live)
Species
Chicken
Anatomical therapeutic chemical veterinary (ATCvet) codes
QI01AE03
Publication details
Marketing-authorisation holder
Pharmsure Veterinary Products Europe Ltd
Revision
5
Date of issue of marketing authorisation valid throughout the European Union
14/06/2011
Contact address

4 Ormond Quay Upper
Dublin
DO7 PF53
Ireland

Product information

21/03/2019 MS-H Vaccine - EMEA/V/C/000161 - II/0013

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • IMMUNOLOGICALS FOR AVES
  • Live bacterial vaccines

Therapeutic indication

For active immunisation of future broiler breeder chickens, future layer breeder chickens and future layer chickens to reduce air sac lesions and reduce the number of eggs with abnormal shell formation caused by Mycoplasma synoviae.

Assessment history

News

How useful was this page?

Add your rating